Current treatment of acute lower extremity deep venous thrombosis

International Journal of Lower Extremity Wounds

Volumn 7, Issue 1, 2008, Pages 15-20

  Janjigian, Michael P ^a   Muhs, Bart E ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AngioJet; Deep venous thrombosis; DVT; Mechanical thrombectomy; Postphlebitic syndrome; Surgical venous thrombectomy; Thrombectomy; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; APIXABAN; BLOOD CLOTTING FACTOR 10A; CONTRAST MEDIUM; DABIGATRAN ETEXILATE; FIBRINOLYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN; THROMBIN; WARFARIN; XIMELAGATRAN;

BLEEDING; BLOOD CLOT LYSIS; CANCER PATIENT; DEEP VEIN THROMBOSIS; DOSE RESPONSE; DRUG SAFETY; HEALTH CARE COST; HUMAN; LONG TERM CARE; LOW DRUG DOSE; MORTALITY; PHLEBOGRAPHY; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; THROMBECTOMY; THROMBOPHILIA;

HUMANS; LEG; POSTTHROMBOTIC SYNDROME; PULMONARY EMBOLISM; RECURRENCE; THROMBECTOMY; VENA CAVA FILTERS; VENOUS THROMBOSIS;

EID: 40549113005     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734608314566     Document Type: Review

References (41)

1. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998 ; 158: 585-593.
2. White RH The epidemiology of venous thromboembolism. Circulation. 2003 ; 107 (23 suppl 1). 14-18.
3. White RH, Zhou H., Romano PS Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med. 1998 ; 128: 737-740.
4. Buller HR, Agnelli G., Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 ;126(3 suppl): 401S-428S.
5. Qaseem A., Snow V., Barry P., et al. Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med. 2007 ; 146: 454-458.
6. Goodacre S., Sampson F., Stevenson M., et al. Measurement of the clinical and cost-effectiveness of non-invasive diagnostic testing strategies for deep vein thrombosis. Health Technol Assess. 2006 ; 10 (15). 1-168, iii - iv.
7. Fancher TL, White RH, Kravitz RL Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review. BMJ. 2004 ; 329 (7470). 821.
8. Kearon C., Ginsberg JS, Kovacs MJ, et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med. 2003 ; 349: 631-639.
9. Prandoni P., Lensing AW, Cogo A., et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996 ; 125: 1-7.
10. Hansson PO, Sorbo J., Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med. 2000 ; 160: 769-774.
11. Heit JA, Mohr DN, Silverstein MD, et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med. 2000 ; 160: 761-768.
12. Kearon C. Long-term management of patients after venous thromboembolism. Circulation. 2004 ; 110 (9 suppl 1). 110-8.
13. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. The Columbus Investigators. N Engl J Med. 1997 ; 337: 657-662.
14. Dolovich LR, Ginsberg JS, Douketis JD, et al. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Intern Med. 2000 ; 160: 181-188.
15. Koopman MM, Prandoni P., Piovella F., et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med. 1996 ; 334: 682-687.
16. Lensing AW, Prins MH, Davidson BL, et al. Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis. Arch Intern Med. 1995 ; 155: 601-607.
17. Levine M., Gent M., Hirsh J., et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med. 1996 ; 334: 677-681.
18. Goldhaber SZ, Buring JE, Lipnick RJ, et al. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med. 1984 ; 76: 393-397.
19. Rogers LQ, Lutcher CL Streptokinase therapy for deep vein thrombosis: a comprehensive review of the English literature. Am J Med. 1990 ; 88: 389-395.
20. Alesh I., Kayali F., Stein PD Catheter-directed thrombolysis (intrathrombus injection) in treatment of deep venous thrombosis: a systematic review. Catheter Cardiovasc Interv. 2007 ; 70: 143-148.
21. Ouriel K., Gray B., Clair DG, et al. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis. J Vasc Interv Radiol. 2000 ; 11: 295-298.
22. Winter C., Weber H., Loeprecht H. Surgical treatment of iliofemoral vein thrombosis technical aspects. Possible secondary interventions. Int Angiol. 1989 ; 8: 188-193.
23. Arko FR, Davis CM III, Murphy EH, et al. Aggressive percutaneous mechanical thrombectomy of deep venous thrombosis: early clinical results. Arch Surg. 2007 ; 142: 513-518 ; discussion 8-9.
24. Decousus H., Leizorovicz A., Parent F., et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med. 1998 ; 338: 409-415.
25. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation. 2005 ; 112: 416-422.
26. Ansell J. Vena cava filters: do we know all that we need to know ? Circulation. 2005 ; 112: 298-299.
27. Ridker PM, Goldhaber SZ, Danielson E., et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med. 2003 ; 348: 1425-1434.
28. Linkins LA, Choi PT, Douketis JD Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med. 2003 ; 139: 893-900.
29. Hirsh J. Oral anticoagulant drugs. N Engl J Med. 1991 ; 324: 1865-1875.
30. Eikelboom JW, Weitz JI A replacement for warfarin: the search continues. Circulation. 2007 ; 116: 131-133.
31. Kahn SR The post-thrombotic syndrome: progress and pitfalls. Br J Haematol. 2006 ; 134: 357-365.
32. Kahn SR, Ginsberg JS Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med. 2004 ; 164: 17-26.
33. Wille-Jorgensen P., Jorgensen LN, Crawford M. Asymptomatic postoperative deep vein thrombosis and the development of postthrombotic syndrome. A systematic review and meta-analysis. Thromb Haemost. 2005 ; 93: 236-241.
34. Ageno W., Piantanida E., Dentali F., et al. Body mass index is associated with the development of the post-thrombotic syndrome. Thromb Haemost. 2003 ; 89: 305-309.
35. van Dongen CJ, Prandoni P., Frulla M., et al. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost. 2005 ; 3: 939-942.
36. Kahn SR, Kearon C., Julian JA, et al. Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost. 2005 ; 3: 718-723.
37. Stain M., Schonauer V., Minar E., et al. The postthrombotic syndrome: risk factors and impact on the course of thrombotic disease. J Thromb Haemost. 2005 ; 3: 2671-2676.
38. Brandjes DP, Buller HR, Heijboer H., et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet. 1997 ; 349: 759-762.
39. Prandoni P., Lensing AW, Prins MH, et al. Below-knee elastic compression stockings to prevent the postthrombotic syndrome: a randomized, controlled trial. Ann Intern Med. 2004 ; 141: 249-256.
40. Ginsberg JS, Hirsh J., Julian J., et al. Prevention and treatment of postphlebitic syndrome: results of a 3-part study. Arch Intern Med. 2001 ; 161: 2105-2109.
41. Kolbach DN, Sandbrink MW, Hamulyak K., et al. Non-pharmaceutical measures for prevention of postthrombotic syndrome. Cochrane Database Syst Rev. 2004 ; (1). CD004174.